News
People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...
7h
HealthDay on MSNADA: Insulin Efsitora Noninferior to Glargine for Reducing HbA1c in Adults With Type 2 DiabetesOnce-weekly insulin efsitora alpha (efsitora) is noninferior to once-daily insulin glargine (glargine) for reducing glycated ...
The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott ...
VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
1d
Everyday Health on MSNDitching Diet Soda Tied to Weight Loss and Higher Chance of Diabetes RemissionWomen with diabetes who were overweight or had obesity lost more weight and had greater odds of diabetes remission when ...
2d
HealthDay on MSNADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With WaterFor adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated ...
Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit ...
For high-risk patients with type 2 diabetes, oral semaglutide reduced risk for major cardiovascular and ischemic limb-related ...
Results presented at the 85th Scientific Sessions of the American Diabetes Association in Chicago highlight the potential for ...
All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results